This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
ReNeuron Holdings, a UK pharmaceutical company developing therapeutics for neurological disorders, completed its initial public offering. It netted about $30mm through the sale of 10.9mm ordinary shares (including the overallotment) at $2.79 apiece.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?